Screening for Clonal Hematopoiesis for Mitigating the Risk of Hematopoietic Neoplasms after PRRT
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Screening for Clonal Hematopoiesis for Mitigating the Risk of Hematopoietic Neoplasms after PRRT ; volume:22 ; number:02 ; year:2023 ; pages:150-151
World Journal of Nuclear Medicine ; 22, Heft 02 (2023), 150-151
- Contributor
-
Chandra, Piyush
Kumar, Kishore
- DOI
-
10.1055/s-0043-1764308
- URN
-
urn:nbn:de:101:1-2023070610300855736805
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:43 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chandra, Piyush
- Kumar, Kishore
Other Objects (12)
Discovering the drivers of clonal hematopoiesis
Clonal hematopoiesis, aging, and cardiovascular diseases
Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders
Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
Clonal hematopoiesis in children with predisposing conditions
Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
Clonal hematopoiesis in patients with rheumatoid arthritis
Compartment-specific mutational landscape of clonal hematopoiesis
Shared and distinct genetic etiologies for different types of clonal hematopoiesis
Deciphering stromal dysregulations in clonal hematopoiesis and myelodysplasia
Unidirectional association of clonal hematopoiesis with atherosclerosis development
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Discovering the drivers of clonal hematopoiesis
Clonal hematopoiesis, aging, and cardiovascular diseases
Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders
Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
Clonal hematopoiesis in children with predisposing conditions
Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
Clonal hematopoiesis in patients with rheumatoid arthritis
Compartment-specific mutational landscape of clonal hematopoiesis
Shared and distinct genetic etiologies for different types of clonal hematopoiesis
Deciphering stromal dysregulations in clonal hematopoiesis and myelodysplasia
Unidirectional association of clonal hematopoiesis with atherosclerosis development
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Discovering the drivers of clonal hematopoiesis
Clonal hematopoiesis, aging, and cardiovascular diseases
Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders
Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
Clonal hematopoiesis in children with predisposing conditions
Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
Clonal hematopoiesis in patients with rheumatoid arthritis
Compartment-specific mutational landscape of clonal hematopoiesis
Shared and distinct genetic etiologies for different types of clonal hematopoiesis
Deciphering stromal dysregulations in clonal hematopoiesis and myelodysplasia
Unidirectional association of clonal hematopoiesis with atherosclerosis development